BridgeMD
DUAL
EU CTIS ID: 2023-505453-40-00
What this study is testing
To confirm lesion-specific uptake of 99mTc-hPSMA by PCa
- Phase I and Phase II (Integrated)- First administration to humans
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Male, aged 18 years and older
- Histopathologically confirmed adenocarcinoma of the prostate
- Had a routine PSMA PET/CT within 90 days before surgery
- PSMA avid tumor on PSMA PET/CT
- Suitable for RALP +ePLND, as per institutional guidelines (no minimum or maximum lesions on PSMA PET)
- Written and signed informed consent
You likely can't join if
- Previous radiotherapy of the abdomen
- Ongoing androgen deprivation therapy (ADT) or within 6 months prior to surgery
- History of other malignancy within 5 years prior to surgery (except skin malignancies)
- Previous or ongoing chemotherapy
- Previous or ongoing immunotherapy
- Severe claustrophobia interfering with PET/CT or SPECT/CT scanning
See the full eligibility criteria
- Male, aged 18 years and older
- Histopathologically confirmed adenocarcinoma of the prostate
- Had a routine PSMA PET/CT within 90 days before surgery
- PSMA avid tumor on PSMA PET/CT
- Suitable for RALP +ePLND, as per institutional guidelines (no minimum or maximum lesions on PSMA PET)
- Written and signed informed consent
- Previous radiotherapy of the abdomen
- Ongoing androgen deprivation therapy (ADT) or within 6 months prior to surgery
- History of other malignancy within 5 years prior to surgery (except skin malignancies)
- Previous or ongoing chemotherapy
- Previous or ongoing immunotherapy
- Severe claustrophobia interfering with PET/CT or SPECT/CT scanning
- History of clinically significant allergies including anaphylaxis
- History of impaired renal function (defined as eGFR<60ml/min/1,73m2)
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.